C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
09/2011
09/08/2011	US20110218154 Histone deacetylases, and uses related thereto
09/06/2011	US8013187 2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α
09/01/2011	US20110212969 Substituted hydroxamic acids and uses thereof
08/2011
08/25/2011	WO2011101321A1 3-aminocarbonyl-substituted benzoylcyclohexanediones and their use as herbicides
08/25/2011	US20110207960 Process For The Preparation Of Iodinated Contrast Agent
08/25/2011	US20110207605 3-Aminocarbonyl-substituted benzoylcyclohexanediones and their use as herbicides
08/24/2011	EP2359828A1 HDAC inhibitors and hormone targeted drugs for the treatment of cancer
08/23/2011	US8003825 Process for producing cycloalkanone oximes
08/18/2011	WO2011097712A1 Hybrid molecule having mixed retinoic acid receptor agonism and histone deacetylase inhibitory properties
08/18/2011	CA2827015A1 Hybrid molecule having mixed retinoic acid receptor agonism and histone deacetylase inhibitory properties
08/17/2011	CN102159537A Organic compounds for applications in bacterial infections treatment
08/17/2011	CN102159203A Activatiqn of histone deacetylase 1 (hdac1) protects against DNA damage and increases neuronal survival
08/17/2011	CN102151262A Compounds for the treatment of metabolic disorders
08/17/2011	CN101519365B Improved production method for salicylhydroxamic acid
08/09/2011	US7994362 Histone deacetylases, and uses related thereto
08/09/2011	US7994357 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
08/03/2011	EP2349985A2 Process for the preparation of vorinostat
08/03/2011	CN102140064A Compounds for the treatment of metabolic disorders
08/02/2011	US7989660 Bactericide against gramnegative bacteria; respiaratory system disorders
07/2011
07/20/2011	EP1697312B1 Hydroxamic acid esters and pharmaceutical use thereof
07/20/2011	EP1481966B1 Novel arylamidine derivative or salt thereof
07/14/2011	US20110172174 Antibacterial agents
07/12/2011	US7977387 Aminobenzophenone compounds
07/06/2011	EP2340241A1 Organic compounds for applications in bacterial infections treatment
07/06/2011	CN1777577B Antibacterial agents
07/05/2011	US7973181 Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activity
07/05/2011	US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
07/05/2011	CA2531484C Novel bioisosteres of actinonin
06/2011
06/29/2011	EP2338886A2 Naphthalene derivatives
06/29/2011	EP2338878A2 N-hydroxyamide derivatives possessing antibacterial activity
06/29/2011	EP1233958B1 Inhibitors of histone deacetylase
06/22/2011	EP2334378A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
06/16/2011	CA2782248A1 Bis-acylated hydroxylamine derivatives
06/09/2011	US20110136878 Amide derivative, pest control agent containing the amide derivative, and pest controlling method
06/08/2011	EP1879895B1 Enzyme inhibitors
06/07/2011	CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors
05/2011
05/31/2011	US7951972 Human adam-10 inhibitors
05/19/2011	WO2011058582A1 Histone deacetylase inhibitors for the treatment of fungal infections
05/19/2011	CA2780772A1 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
05/19/2011	CA2780433A1 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
05/18/2011	EP2322160A1 Methods of inducing terminal differentiation
05/18/2011	EP1698618B1 Benzamide derivative
05/18/2011	CN101311165B Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
05/12/2011	WO2011056983A1 Zirconium-radiolabeled, cysteine engineered antibody conjugates
05/12/2011	WO2011055843A1 Retinoid compound
05/12/2011	US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors
05/12/2011	CA2780216A1 Zirconium-radiolabeled, cysteine engineered antibody conjugates
05/11/2011	EP2318355A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
05/11/2011	EP2317994A2 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
05/10/2011	US7939666 Enzyme inhibitors
05/05/2011	US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
05/04/2011	EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
04/2011
04/28/2011	WO2010115758A3 Fungicidal compounds
04/28/2011	US20110098504 Histone Deacetylase Inhibitors and Methods of Use Thereof
04/26/2011	CA2477657C Cathepsin cysteine protease inhibitors
04/20/2011	CN102020588A Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof
04/13/2011	CN101444496B Compounds for the treatment of metabolic disorders
04/12/2011	US7923579 Tricyclic hydroxamate and benzamide derivatives, compositions and methods
04/06/2011	EP1780197B9 5-substituted-2-phenylamino benzamides as mek inhibitors
04/05/2011	US7919528 Antibiotic; bactericides
03/2011
03/30/2011	EP2301939A1 Enzyme inhibitors
03/17/2011	US20110064677 Lipoxin analogs and methods for the treatment of periodontal disease
03/16/2011	EP2295402A2 Antibacterial agents
03/16/2011	CN101985428A O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof
03/08/2011	US7902259 with zinc-binding activities; 5-phenyl-2,4,-pentadienoyl hydroxamic acid; gene expression inhibitor; anticarcinogenic, antitumor, antiprotozoa agent, viricide; hematological disorders, hemoglobinopathies, genetic related metabolic disorders, cystic fibrosis
03/08/2011	CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors
03/03/2011	WO2011023706A1 Process for the preparation of a glucokinase activator compound
03/03/2011	WO2011006908A3 Metal complexes having dual histone deacetylase inhibitory and dna-binding activity
03/02/2011	CN101982459A Preparation technology of acetohydroxamic acid
02/2011
02/24/2011	WO2011021209A1 Histone deacetylase inhibitors
02/24/2011	WO2010086860A3 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
02/08/2011	US7884246 Process for preparing substituted anisidines
02/08/2011	US7884242 N-heterocyclylphthaldiamides as insecticides
02/08/2011	CA2442319C Carboxylic acid derivative and salt thereof
02/01/2011	US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
02/01/2011	US7879911 2-(4-Fluorophenoxy-N-hydroxyacetamide where the "oxy" can also be sulfonyl, sulfamyl or sulfinyl; enzyme inhibitors of the "lethal factor" enzyme released by bacillus anthraci that splits an essential peptide needed by mammals for signal transmission; antidotes; biological warfare
01/2011
01/27/2011	US20110021528 Novel hydroxamates as therapeutic agents
01/05/2011	CN101939289A Novel process for the preparation of vorinostat
01/04/2011	US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active
01/04/2011	CA2319672C Compounds and compositions for delivering active agents
12/2010
12/29/2010	EP2266954A1 Novel bifunctional chelating compounds containing hydroxamic acid residues
12/29/2010	EP2266953A1 Novel bifunctional chelating compounds containing hydroxamic acid residues
12/29/2010	EP2266552A2 Methods of inducing terminal differentiation
12/29/2010	CN101928234A 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same
12/28/2010	US7858664 Contacting cells with a zinc-binding compounds, having effective amount of carboxylic acid derivative or hydroxamic acid derivative inhibitor compound; treating cancer, blood disorders, genetic related metabolic disorders; 3-methyl-5-phenyl-2,4-pentadienoic acid
12/23/2010	US20100324025 Antibacterial Agents
12/22/2010	EP2263995A1 Para-tert-butylcalix[6]arenes with triacid fuctional groups in positions 2, 4 and 6, as well as supported liquid membranes and support material comprising such membranes and their use
12/21/2010	US7855302 New sterospecifc chemical intermediates for statin drugs as astatin side chain building block to allow for a convergent ssynthesis; monoethyl ester of (3R)-acetoxyglutaaric acid chloride; efficiency;
12/15/2010	EP2261208A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010	EP2261207A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010	CN101918389A Inhibitors of histone deacetylase
12/14/2010	US7851509 Polymorphs of suberoylanilide hydroxamic acid
12/14/2010	US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
12/08/2010	EP2258677A2 Histone deacetylase inhibitors and methods of use thereof
12/07/2010	US7847122 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time
11/2010
11/30/2010	US7842835 Increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases; such as n-hydroxy-4-[3-(2-hydroxy-2-phenyl-ethyl)-ureido]-butyramide
11/25/2010	WO2010133748A1 Protease inhibitors
11/25/2010	US20100298554 Compounds and methods for labeling oligonucleotides
11/25/2010	CA2758222A1 Protease inhibitors
11/24/2010	EP1280764B1 Inhibitors of histone deacetylase

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 45